Xilio Therapeutics, Inc. Other Nonoperating Expense
Xilio Therapeutics, Inc. (XLO) reported Other Nonoperating Expense of $129.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued
us-gaap:OtherNonoperatingExpense · last filed 2022-05-12
- Xilio Therapeutics, Inc. other nonoperating expense for the quarter ending 2022-03-31 was $129.00K, a 12.24% decline year-over-year.
- Xilio Therapeutics, Inc. other nonoperating expense for the quarter ending 2021-12-31 was $145.00K, a 18.08% decline year-over-year.
- Xilio Therapeutics, Inc. other nonoperating expense for the quarter ending 2021-09-30 was $290.00K, a 47.96% increase year-over-year.
- Xilio Therapeutics, Inc. other nonoperating expense for the quarter ending 2021-03-31 was $147.00K.
- Xilio Therapeutics, Inc. other nonoperating expense for fiscal 2021 was $756.00K, a 15.24% increase from fiscal 2020.
- Xilio Therapeutics, Inc. other nonoperating expense for fiscal 2020 was $656.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2022-03-31 | $129.00K 10-Q · filed 2022-05-12 | $274.00K derived: sum of 2 quarters · filed 2022-05-12 | $564.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2021-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $435.00K derived: sum of 2 quarters · filed 2022-03-01 | $756.00K 10-K · filed 2022-03-01 | |
| 2021-09-30 | $290.00K 10-Q · filed 2021-12-02 | $611.00K 10-Q · filed 2021-12-02 | ||
| 2021-03-31 | $147.00K 10-Q · filed 2022-05-12 | $324.00K derived: sum of 2 quarters · filed 2022-05-12 | $520.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $373.00K derived: sum of 2 quarters · filed 2022-03-01 | $656.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $196.00K 10-Q · filed 2021-12-02 | $479.00K 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |